GLOBAL HEALTHCARE TRANSACTIONS AND BUSINESS STRATEGY

Advised

Precious Cells Group

Adult Stem Cell Biobanking

By Private Investors

Undisclosed

2016

Strategic Alliance

CNSystems

Non-Invasive Hemodynamic Monitoring

To Pulsion

Undisclosed

2016

License

Aucta Pharmaceuticals

Generic Drug

To Upsher Smith

Undisclosed

2016

Corporate Licensing

Imaginot

Fast Acting Drug Delivery Technology

To Global Corporate Pharma

Undisclosed

2015

Strategic Alliance

Hemispherx Biopharma

Early Access Program

With Undisclosed

Undisclosed

2015

Financing

Regenerys Ltd

Regenerative Medicine

By Private Investors

£500,000

2014

Financing

PneumaCare

Respiratory Medical Devices

By Private Investors

$800,000

2014

Asset Aquisition of

Palau Pharmaceuticals

Albaconazole Anti Fungal Product

By Actavis

Undisclosed

2013

Financing

PneumaCare

Respiratory Medical Device

By Investor Consortium

$1,600,000

2013

License

Mediglobe

Nutraceutical for IBS

To Schwabe North America

Undisclosed

2013

Advised

Joint Polish Investment Fund

Public/Private Initiative

With Polish Government

$75,000,000

2013

The Sale of

Palau Pharma Asset

Albaconazole Dermatology Asset

To Actavis

Undisclosed

2013

License

Surgedose

Drug Delivery Technology

To Undisclosed

Undisclosed

2013

Aquisition of

Altrika

Regenerative Medicine

By Regenerys

Undisclosed

2012

Advised

Giltech

Biomaterials Technology Partnering

Undisclosed

2012

Financing

PneumaCare

Medical Technology for Respiratory Disease

By Private Investors

£2,100,00

2011